Poviztra is a second brand of Wegovy
Emcure Pharmaceuticals has reported total income of Rs. 2,104.23 crores during the period ended June 30, 2025
Emcure Pharmaceuticals successfully completes USFDA PAI of Oncology facility
The transaction is expected to close in Q2 FY 2026
Vidya will spark conversations around less discussed and important aspects of health, including intimate care and sleep issues
USFDA inspection at Emcure Pharmaceuticals API facility
Arth by Emcure is a specialized range of supplements designed to address the unique health and wellness needs of women, enabling them to lead healthier and happier lives across all stages
Subscribe To Our Newsletter & Stay Updated